Get Started

EQ

NASD Equillium, Inc.
Nov 4, 2026 · 11:37 PM ET EOD Market Closed

$1.40 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.40, $0.12 below the day’s high of $1.52

YTD change
-9.68%
vs 20-day SMA
+3.63%
vs 200-day SMA
-32.74%

Price ranges

Previous day
$1.36 $1.46
open $1.38 close $1.41
+$0.03 (+2.17%)
Today
$1.35 $1.52
open $1.49 now $1.40
-$0.09 (-6.04%)
Past week
$1.29 $1.48
from $1.36 now $1.40
+$0.04 (+2.94%)
Past month
$1.16 $1.51
from $1.42 now $1.40
-$0.02 (-1.41%)
This year
$1.05 $3.54
from $1.55 now $1.40
-$0.15 (-9.68%)

Price & Performance

-0.70 (-33.33%) / 6M

$1.03$1.81$2.58$3.36May 4Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 94.8% away from all-time highs of $27.05
  • EQ is down 10% since the beginning of the year
  • EQ is down 3% over the past 12 months
  • EQ is down 1% over the past 1 month
  • 13% of all EQ investors are betting against EQ

EQ reads neutral: price sits above one of the two key moving averages, the 12-month move is -2.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.04
Earnings momentum +18.4% Quarterly EPS growth
Quarterly change +18.4%

Valuation

P/E ratio N/A
Enterprise value $101.1M
Beta 3.07

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$57.2M
Debt$584.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $204.0M

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.